DE69906303D1 - Cyclische verbindungen zur behandlung von dyslipidämien, atheriosklerose und diabetes, pharmazeutische zusammensetzungen und herstellungsverfahren - Google Patents

Cyclische verbindungen zur behandlung von dyslipidämien, atheriosklerose und diabetes, pharmazeutische zusammensetzungen und herstellungsverfahren

Info

Publication number
DE69906303D1
DE69906303D1 DE69906303T DE69906303T DE69906303D1 DE 69906303 D1 DE69906303 D1 DE 69906303D1 DE 69906303 T DE69906303 T DE 69906303T DE 69906303 T DE69906303 T DE 69906303T DE 69906303 D1 DE69906303 D1 DE 69906303D1
Authority
DE
Germany
Prior art keywords
diabetes
atheriosclerosis
pharmaceutical compositions
production methods
cyclic compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69906303T
Other languages
English (en)
Other versions
DE69906303T2 (de
Inventor
Jean-Jacques Berthelon
Daniel Guerrier
Eric Rasp
Jean-Jacques Zeiller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of DE69906303D1 publication Critical patent/DE69906303D1/de
Application granted granted Critical
Publication of DE69906303T2 publication Critical patent/DE69906303T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/081,3-Dioxanes; Hydrogenated 1,3-dioxanes condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/061,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE69906303T 1998-07-17 1999-07-09 Cyclische verbindungen zur behandlung von dyslipidämien, atheriosklerose und diabetes, pharmazeutische zusammensetzungen und herstellungsverfahren Expired - Fee Related DE69906303T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9809164A FR2781222A1 (fr) 1998-07-17 1998-07-17 Composes cycliques utilisables dans le traitement de dyslipidemies, de l'atherosclerose et du diabete, compositions pharmaceutiques les contenant et procede de preparation
PCT/EP1999/004831 WO2000004011A1 (en) 1998-07-17 1999-07-09 Cyclic compounds useful in the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions and preparation process

Publications (2)

Publication Number Publication Date
DE69906303D1 true DE69906303D1 (de) 2003-04-30
DE69906303T2 DE69906303T2 (de) 2003-12-11

Family

ID=9528730

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69906303T Expired - Fee Related DE69906303T2 (de) 1998-07-17 1999-07-09 Cyclische verbindungen zur behandlung von dyslipidämien, atheriosklerose und diabetes, pharmazeutische zusammensetzungen und herstellungsverfahren

Country Status (22)

Country Link
US (1) US6528538B1 (de)
EP (1) EP1098893B1 (de)
JP (1) JP2002520407A (de)
KR (1) KR20010070966A (de)
CN (1) CN1309655A (de)
AT (1) ATE235485T1 (de)
AU (1) AU753287B2 (de)
BR (1) BR9912138A (de)
CA (1) CA2337481A1 (de)
DE (1) DE69906303T2 (de)
DK (1) DK1098893T3 (de)
ES (1) ES2192853T3 (de)
FR (1) FR2781222A1 (de)
HK (1) HK1039615A1 (de)
HU (1) HUP0103411A3 (de)
ID (1) ID27854A (de)
NO (1) NO20010266D0 (de)
PL (1) PL345397A1 (de)
PT (1) PT1098893E (de)
SK (1) SK482001A3 (de)
WO (1) WO2000004011A1 (de)
ZA (1) ZA200101303B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI311133B (en) 2001-04-20 2009-06-21 Eisai R&D Man Co Ltd Carboxylic acid derivativeand the salt thereof
JPWO2003016265A1 (ja) * 2001-08-17 2004-12-02 エーザイ株式会社 環状化合物およびpparアゴニスト
RU2379303C2 (ru) 2003-04-24 2010-01-20 Инсайт Корпорейшн Производные азаспироалканов в качестве ингибиторов металлопротеаз
WO2005077943A1 (en) * 2004-01-09 2005-08-25 Cadila Healthcare Limited 1 , 3 - dioxane derivatives and analogues thereof useful in the treatment of i.a. obesity and diabetes
JP2008510696A (ja) * 2004-08-20 2008-04-10 カディラ ヘルスケア リミティド 新規抗糖尿病化合物
CN100389112C (zh) * 2004-12-16 2008-05-21 中国石油化工股份有限公司 一类环状缩醛和缩酮化合物及其应用
CA2633440C (en) * 2006-02-27 2011-06-21 Cadila Healthcare Limited 1,3-dioxane carboxylic acids
JP2009537559A (ja) * 2006-05-18 2009-10-29 ウェルスタット セラピューティクス コーポレイション 代謝障害の処置のための化合物
US7910108B2 (en) * 2006-06-05 2011-03-22 Incyte Corporation Sheddase inhibitors combined with CD30-binding immunotherapeutics for the treatment of CD30 positive diseases
WO2016056031A1 (en) 2014-10-08 2016-04-14 Council Of Scientific & Industrial Research Novel diol compounds synthesis and its use for formal synthesis of (2r, 3 s)-3-hydroxypipecolic acid
US9637575B2 (en) * 2014-12-31 2017-05-02 W. R. Grace & Co. -Conn. Catalyst system, olefin polymerization catalyst components comprising at least an internal electron donor compound, and methods of making and using the same
US20230050418A1 (en) * 2019-12-13 2023-02-16 Rhodia Operations Production of benzene derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4032536A (en) 1976-07-22 1977-06-28 Janssen Pharmaceutica N.V. (1h-benzimidazol-2-yl)carbamates
US5179216A (en) * 1990-08-16 1993-01-12 American Home Products Corporation N,n', n'-trisubstituted-5-bisaminomethylene-1,3-dioxane-4,6-dione inhibitors of acyl-coa:cholesterol-acyl transferase
TW209868B (de) * 1991-04-04 1993-07-21 Yoshitomi Pharmaceutical
DE19637840A1 (de) * 1996-09-17 1998-03-19 Henkel Kgaa Verwendung von geminalen Dialkoxyalkansäureestern zur Herstellung von desodorierenden Körperpflegemitteln

Also Published As

Publication number Publication date
ZA200101303B (en) 2002-05-15
AU753287B2 (en) 2002-10-17
HK1039615A1 (zh) 2002-05-03
ATE235485T1 (de) 2003-04-15
BR9912138A (pt) 2001-04-10
PL345397A1 (en) 2001-12-17
US6528538B1 (en) 2003-03-04
ES2192853T3 (es) 2003-10-16
EP1098893B1 (de) 2003-03-26
DK1098893T3 (da) 2003-07-07
AU5034799A (en) 2000-02-07
CA2337481A1 (en) 2000-01-27
NO20010266L (no) 2001-01-16
HUP0103411A3 (en) 2002-08-28
JP2002520407A (ja) 2002-07-09
PT1098893E (pt) 2003-08-29
HUP0103411A2 (hu) 2002-04-29
FR2781222A1 (fr) 2000-01-21
CN1309655A (zh) 2001-08-22
ID27854A (id) 2001-04-26
NO20010266D0 (no) 2001-01-16
SK482001A3 (en) 2001-09-11
EP1098893A1 (de) 2001-05-16
DE69906303T2 (de) 2003-12-11
KR20010070966A (ko) 2001-07-28
WO2000004011A1 (en) 2000-01-27

Similar Documents

Publication Publication Date Title
DE602005014955D1 (de) Verbindungen und verfahren zur behandlung von dyslipidämie
DE69906303T2 (de) Cyclische verbindungen zur behandlung von dyslipidämien, atheriosklerose und diabetes, pharmazeutische zusammensetzungen und herstellungsverfahren
GB0305152D0 (en) Organic compounds
MXPA03009840A (es) Derivados de fenilurea sustituidos con carboxamida y metodo para la produccion de los mismos como farmacos.
ATE421322T1 (de) Chinolin-2-on-derivate zur behandlung von erkankungen der atemwege
ATE396174T1 (de) Hydroxyalkylaminderivate als beta-secretase- inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten
ATE525067T1 (de) Amino-substituierte (e)-2,6-dialkoxystyryl 4- substituierte benzylsulfone zur behandlung von proliferierenden erkrankungen
ATE424385T1 (de) 1-(4-piperidinyl)-1,3-dihydro-2h-benzoxazole-2- one derivate und verwandte verbindungen als nociceptin analoge und orl1 liganden zur behandlung von schmerz
DE60326358D1 (de) Fasern und fibride enthaltende artikel, fasern und fibride und herstellungsverfahren
ATE293976T1 (de) Verbindungen enthaltend s-tofisopam sowie verwendung dieser verbindungen zur herstellung eines medikamentes zur behandlung oder prophylaxe von krämpfen und anfällen
YU40002A (sh) Antipikornavirusna jedinjenja i kompozicije, njihove farmaceutske upotrebe, i materijali za njihove sinteze
SE0300850D0 (sv) Chemical compounds
ATE302002T1 (de) Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit
SE0200844D0 (sv) Chemical compounds
DE602004028574D1 (de) Zusammensetzungen und verfahren zur behandlung des reizdarmsyndroms und von nichtulzeröser dyspepsie
DE602004021363D1 (de) Imidazotriazin verbindungen zur behandlung von krebserkrankungen
DE69429856D1 (de) Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit
ATE397924T1 (de) Satraplatin zur behandlung von resistenten oder refrkatären tumoren
DE69307674D1 (de) HIV-Proteaseinhibitoren und ihre Verwendung zur Behandlung von AIDS
DE602004023102D1 (de) Verfahren zur herstellung kristalliner formen von orlistat
CY1110156T1 (el) Υποκατεστημενες ενωσεις 4,5,6,7-τετραϋδρο-βενζοθειαζολ-2-υλαμινης
ATE274513T1 (de) Verbindungen und verfahren zur behandlung von schmerz
HUP0302408A2 (hu) Új aminotriazolon-vegyületek, eljárás ezek előállítására és ezeket tartalmazó gyógyászati készítmények
DE60335980D1 (de) Verfahren zur herstellung von synthetischen derivaten von dibenzylbutyrolacton-lignanen mit antichagas eigenschaften
ATE460168T1 (de) Nicht-radioaktives strontiummittel zur behandlung von krebs

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee